Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*)

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 3, 1996, Pages 245-253

  Moorehead, Roger A ^a   Armstrong, Steven G ^b   Rainbow, Andrew J ^a   Singh, Gurmit ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Cisplatin; DNA repair; Host cell reactivation

Indexed keywords

APHIDICOLIN; CELL DNA; CISPLATIN; DNA; DNA DIRECTED DNA POLYMERASE ALPHA; VIRUS DNA;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; DRUG POTENTIATION; DRUG RESISTANCE; FEMALE; HOST CELL; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; REPORTER GENE;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS; APHIDICOLIN; CARCINOMA; CELL SURVIVAL; CISPLATIN; DNA ADDUCTS; DNA DAMAGE; DNA POLYMERASE II; DNA REPAIR; DNA, VIRAL; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; HUMANS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029951476     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050478     Document Type: Article

References (45)

1. Andrews PA, Albright KD (1992) Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res 52:1895
2. Armstrong SG, Browman GP, Benger AM, Meyer RM, McKay KL, Singh G (1994) Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia. Leukemia Res 18:659
3. Bohr VA (1991) Gene specific DNA repair. Carcinogenesis 12:1983
4. Bohr VA, Chu EHY, Duin M, van Hanawalt PC, Okumoto DS (1988) Human repair gene restores normal pattern of preferential DNA repair in repair defective CHO cells. Nucleic Acids Res 16:7397
5. Calsou P, Salles B (1993) Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Cancer Chemother Pharmacol 32:85
6. Chao CC-K, Huang S-L, Huang H, Lin-Chao S (1991) Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA. Mol Cell Biol 11:2075
7. Chu G (1994) Cellular responses to cisplatin. J Biol Chem 269:787
8. Collins A, Johnson RT (1987) DNA repair mutants in higher eukaryotes. J Cell Sci [Suppl] 6:61
9. Day III RS, Giuffrida AS, Dingman CW (1975) Repair by human cells of adenovirus-2 damaged by psoralen plus near ultraviolet light treatment. Mutat Res 33:311
10. Fornace AJ Jr (1992) Mammalian genes induced by radiation; activation of genes associated with growth control. Ann Rev Genet 26:507
11. Fornace AJ Jr, Alamo I Jr, Hollander C (1988) DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85:8800
12. Graeff A, de Slebos RJC, Rodenhuis S (1988) Resistance to cisplatin and analogues: mechanisms and potential clinical implications. Cancer Chemother Pharmacol 22:325
13. Hoeijmakers JHJ, Bootsma D (1994) Incisions for excision. Nature 371:654
14. Horwitz MS (1990) Adenoviridae and their replication. In: Fields BN, Knipe DM (eds) Virology. Raven Press, New York, p 1679
15. Hoy CA, Thompson LH, Mooney CL, Salazar EP (1985) Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res 45:1737
16. Jekunen AP, Hom DK, Alcaraz JE, Eastman A, Howell SB (1994) Cellular pharmacology of dichloro(ethylenediamine) platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cells. Cancer Res 54:2680
17. Johnson SW, Perez RP, Godwin AK, Yeung AT, Handel LM, Ozols RF, Hamilton TC (1994) Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem Pharmacol 47:689
18. Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC (1994) Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and resistant human ovarian cancer cells. Cancer Res 54:5911
19. Jones JC, Zhen W, Reed E, Parker RJ, Sancar A, Bohr VA (1991) Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese Hamster ovary cells. J Biol Chem 266:7101
20. Katz EJ, Andrews PA, Howell SB (1990) The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cells. Cancer Commun 2:159
21. Link CJ Jr, Bohr VA (1991) DNA repair in drug resistance: studies on the repair process at the level of the gene. Cancer Treat Res 57:209
22. Link CJ Jr, Burt RK, Bohr VA (1991) Gene-specific repair of DNA damage induced by UV irradiation and cancer chemotherapeutics. Cancer Cells 3:427
23. Maynard KR, Hosking LK, Hill BT (1989) Use of host cell reactivation of cisplatin-treated adenovirus 5 in human cell lines to detect repair of drug-treated DNA. Chem Biol Interact 71:353
24. Moorehead RA, Armstrong SG, Wilson BC, Singh G (1994) Cross-resistance to cisplatin in cells resistant to photofrin-mediated photodynamic therapy. Cancer Res 54:2556
25. Parker RJ, Eastman A, Bostick-Bruton F, Reed E (1991) Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J Clin Invest 87:772
26. Parsons PG, Maynard KR, Little JH, McLeod GR (1986) Adenovirus replication as an in vitro probe for drug sensitivity in human tumors. Eur J Cancer Clin Oncol 22:401
27. Parsons PG, Lean J, Kable EPW, Favier D, Khoo SK, Hurst T, Holmes RS, Bellet AJD (1990) Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isozymes and adenovirus replication in human tumour cell lines. Biochem Pharmacol 40:2641
28. Perez RP, Hamilton TC, Ozols RF (1990) Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems. Pharmacol Ther 48:19
29. Plooy ACM, Dijk M, van Berends F, Lohman PHM (1985) Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). Cancer Res 45:4178
30. Poll EHA, Abrahams PJ, Arwert F, Eriksson AW (1984) Host-cell reactivation of cis-diamminedichloroplatinum(II)-treated SV40 DNA in normal human, Fanconi anaemia and xeroderma pigmentosum fibroblasts. Mutat Res 132:181
31. Rago R, Mitchen J, Wilding G (1990) DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem 191:31
32. Rainbow AJ (1981) Reactivation of viruses. In: Stich HF, San RHC (eds) Short-term tests for chemical carcinogenesis. Springer, New York, 1981, pp 20-35
33. Rideout DC, Chou TC (1991) Synergism, antagonism, and potentiation in chemotherapy: an overview. In: Chou TC, Rideout DC (eds) Synergism and antagonism in chemotherapy. Academic Press, San Diego, pp 3-60
34. Scanlon KJ, Kashani-Sabet M, Tone T, Funato T (1991) Cisplatin resistance in human cancers. Pharmacol Ther 52:385
35. Setlow RB, Regan JD, German J, Carrier WL (1969) Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc Natl Acad Sci USA 64:1035
36. Sheibani N, Jennerwein MM, Eastman A (1989) DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. Biochemistry 28:3120
37. So AG, Downey KM (1988) Mammalian DNA polymerases alpha and delta: current status in DNA replication. Biochemistry 27:4590
38. Swinnen LJ, Fisher SG, Erickson LC (1989) Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis-and trans-diamminedichloroplatinum(II). Carcinogenesis 10:1465
39. Tanaka K, Wood RD (1994) Xeroderma pigmentosum and nucleotide excision repair of DNA. Trends Biochem Sci 19:83
40. Venema J, Mullenders LHF, Natarajan AT, Van Zeeland AA, Mayne LV (1990) The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc Natl Acad Sci USA 87:4704
41. Wei S-J C, Chang RL, Bhachech N, Cui XX, Merkler KA, Wong C-Q, Hennig E, Yagi H, Jerina DM, Conney AH (1993) Dose-dependent differences in the profile of mutations induced by ( + )-7R,8S-dihydroxy-9S, 10R-epoxy-7,8,9,10-tetrahydrobenzo-(a)pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V-79 cells. Cancer Res 53:3294
42. Zhang Y-Z, Naleway JJ, Larison KD, Huang Z, Haugland RP (1991) Detecting lacZ gene expression in living cells with new lipophilic, fluorogenic β-galactosidase substrates. FASEB J 5:3108
43. Zhen W, Link CJ, Jr O'Connor PM, Reed E, Parker R, Howell SB, Bohr VA (1992) Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol 12:3689
44. Zinkewich-Peotti K, Andrews PA (1992) Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance. Cancer Res 52:1902
45. Zwelling LA, Kohn WJ (1982) Platinum complexes. In: Chabner B (ed) Pharmacologic principles of cancer treatment. W.B. Saunders, Philidelphia, pp 309-339